Conference
Late Breaking Abstract - Patients with severe eosinophilic asthma achieved remission over 2 years with benralizumab: Integrated analysis of the >1000-patient, multinational, real-world XALOC-1 study
Authors
Pelaia G; Jackson DJ; Nair P; Emmanuel B; Tran TN; Menzies-Gow A; Watt M; Kayaniyil S; Boarino S; Nuevo J
Publisher
European Respiratory Society (ERS)
Publication Date
September 9, 2023
DOI
10.1183/13993003.congress-2023.pa4131
Name of conference
Airway pharmacology and treatment